Vortex Biosciences announces Dr. Adrian Kinkaid as new CEO

London, UK 2nd June 2021 (PR WEB) EMV Capital portfolio company, Vortex Biosciences, the cancer diagnosis biotechnology business, has announced the appointment of Dr Adrian Kinkaid as its new Chief Executive Officer. Vortex Biosciences has developed the VTX-1, a best-in-class instrument that isolates and purifies Circulating Tumor Cells (CTCs) from blood. These cells can then […]

READMORE

Nick Salisbury joins EMV Capital as Senior Private Client Manager.

Nick Salisbury

EMV Capital is pleased to announce the addition of Nick Salisbury to the position of Senior Private Client Manager in our investor relations department. January 13th, 2020, London EMV Capital continues to expand its team, in support of the companies’ growth strategies. This Investor Relations hire will help EMV Capital support its growing private investor […]

READMORE

EMV Capital wins the ‘Industry Rising Star’ Awards at the Growth Investor Awards 2019

Industry Rising Star

EMV Capital named as a winner in the fifth annual Growth Investor Awards Identified as a market leader in the award for Industry Rising Star   London November 13th, 2019 EMV Capital has been named winner in the fifth annual Growth Investor Awards on Wednesday 6th November, the landmark event that celebrates the standout investment […]

READMORE

EMV Capital joins Kelvin Capital and Scottish Investment Bank to invest in Edinburgh-based Sofant Technologies.

Sofant Technologies has secured investment of £1.8m to finalize its RF MEMS development and bring its millimetre wave antenna technology to market Unique, ultra-low power, low cost modular design which targets millimetre wave SatCom and 5G applications – expected to be at the core of data connectivity for Industrial IoT and other applications Led by […]

READMORE

Q-bot, an EMV Capital portfolio company secures £3m in funding to scale its robotics offering for the construction industry

VC investment in Robotics

[LONDON, UK] London-based Q-Bot, an EMVC portfolio robotics company that has developed a solution to remotely apply underfloor insulation, has successfully completed a £3m Series A investment round to fund the next stage of its growth. Q-Bot has developed a range of robotic and AI technologies that can survey, maintain and upgrade buildings. Q-Bot uses […]

READMORE

EMV Capital invests in leading San Francisco-based liquid biopsy company Vortex Biosciences Inc 

EMV Capital invests in leading San Francisco-based liquid biopsy company Vortex Biosciences Inc  Vortex is a leader in liquid biopsy of circulating tumor cells (CTCs) The Vortex Biosciences VTX-1 instrument is fully automated, providing highly purified, intact CTCs in approximately 1 hour These CTCs are available for downstream fluorescence, genomics, cell culture, PDOX and single […]

READMORE

EMV Capital completes the acquisition of Wanda Inc, a leading telehealth company in Silicon Valley

EMV Capital completes the acquisition of Wanda Inc, a leading telehealth company in Silicon Valley • Wanda, headquartered in San Francisco, is a leader in providing AI-based virtual care applications optimizing care for patients with heart failure and other chronic diseases • The platform warns of pending adverse events seven days before they occur, reducing […]

READMORE

“Top Ten Reasons to Back Smart City Investment Opportunities” – What Investment features Ilian Iliev’s article on smart city opportunities

WhatInvestment Top 10 reasons

What Investment features EMV Capital’s Ilian Iliev’s Article on Smart Cities as a Global opportunity – highlighting some of the exciting trends and technologies in this growing space. Smart Cities harness the benefits of innovation and information technology by improving the lives of their inhabitants and by becoming more streamlined, efficient and sustainable. Some of […]

READMORE

“Who are EIS investors?” – FT Adviser features Ilian Iliev’s article on the ‘typical EIS investor’

FT Adviser-Who are EIS Investors

The FT Adviser features EMV Capital’s Ilian Iliev’s Article on the typical EIS investor profile, and how their goals and objectives shape the ecosystem. The old model of a once-a-year tax affairs review and largely passive allocation of investments may be coming to an end. Increasingly, advisers will be under pressure to innovate to remain […]

READMORE